Comparative genomics reveals polyphyletic emergence of methicillin-resistant Staphylococcus aureus ST152 from a diverse methicillin-susceptible population in ghana Authors: Brown Beckley, Vincent Amarh, Adesola Olalekan, Innocent Afeke Published: 2026 ABSTRACT AbstractBackgroundStaphylococcus aureus is a major public health threat in Ghana, with the Sequence Type 152 (ST152) lineage emerging as a dominant, Panton-Valentine leukocidin toxin (PVL)-positive lineage. This study investigates the evolutionary dynamics and emergence of methicillin resistance within the ST152 population in Ghana.MethodsWe analyzed 285 publicly available S. aureus whole-genome sequences (WGS) from Ghana, encompassing isolates of human and animal origin. Comprehensive genomic characterization was performed using the StaphScope pipeline, followed by detailed pangenome and phylogenetic analyses of 80 ST152 isolates.ResultsST152 was the most prevalent lineage (28.1%). Phylogenetic analysis revealed patterns consistent with polyphyletic emergence of methicillin-resistant S. aureus (MRSA) ST152 through multiple independent acquisitions of the staphylococcal cassette chromosome mec (SCCmec). Despite these multiple origins, a single MRSA-enriched sublineage has become dominant. This successful clade is characterized by the significant enrichment of additional resistance genes (catA, tet(K)), a specific plasmid replicon (rep7a_5_repD(pTZ4)), and the collagen adhesin gene (cna), which may enhance host colonization and transmission. Interestingly, methicillin-susceptible S. aureus (MSSA) isolates were found phylogenetically embedded within MRSA clusters, indicating a highly dynamic resistance landscape.ConclusionsThe emergence of MRSA ST152 in Ghana is a complex, multi-origin process. The dominance of a specific sublineage harboring enhanced virulence and resistance markers suggests a specialized adaptation that facilitates its epidemiological success. These findings underscore the critical need for sustained genomic surveillance to monitor the evolution and spread of high-risk MRSA lineages in West Africa.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12866-026-05131-3.Keywords: ST152, Staphylococcus aureus, MRSA, Ghana, Antimicrobial resistance (AMR), Africa, Phylogeny Introduction Staphylococcus aureus is a versatile pathogen responsible for infections ranging in clinical severity from superficial skin and soft tissue infections to life-threatening invasive diseases [1]. In sub-Saharan Africa, and specifically in Ghana, S. aureus poses a substantial public health burden due to the high prevalence of virulence factors such as Panton-Valentine leukocidin (PVL) and the increasing emergence of methicillin-resistant S. aureus (MRSA) [2, 3]. Recent surveillance in Ghanaian hospitals has documented MRSA proportions as high as 38%, with a significant correlation between PVL-positivity and clinical disease [1, 4]. Among the diverse lineages circulating in West Africa, Clonal Complex 152 (CC152), particularly Sequence Type 152 (ST152), has emerged as a dominant and clinically significant lineage [5, 6]. ST152 is characteristically PVL-positive and has historically been associated with methicillin-susceptible S. aureus (MSSA) populations in the region [6]. However, recent genomic studies indicate a shifting epidemiology, with an increasing frequency of ST152 MRSA isolates in clinical settings [1, 2]. Genomic analyses suggest that this transition is driven by multiple, independent acquisitions of the staphylococcal cassette chromosome mec (SCCmec), highlighting a polyphyletic emergence of resistance within this lineage [7]. Despite the growing importance of ST152, the specific evolutionary dynamics and the extent of its diversification from local MSSA populations in Ghana remain incompletely understood. Understanding whether these MRSA lineages represent a single clonal expansion or independent local emergence events is critical for implementing effective infection control and antimicrobial stewardship [3, 8, 9]. In this study, we utilize comparative genomics and whole-genome sequencing (WGS) data of 285 S. aureus isolates from Ghana to elucidate the population structure and evolutionary trajectory of ST152, providing insights into the emergence of methicillin resistance within this prominent African lineage. Materials and methods Genome sequence data collection and quality assessment Publicly available S. aureus WGS from Ghana were retrieved by searching the National Center for Biotechnology Information (NCBI) and European Nucleotide Archive (ENA) databases using the keywords “Staphylococcus aureus” AND “Ghana” across all available BioProjects (search date: 5th January 2026). From the multiple projects returned, we selected five BioProjects that met the following inclusion criteria: (1) WGS data available; (2) isolates of human and/or animal origin from Ghana; and (3) submitted by the Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana. We restricted to NMIMR submitted genomes to ensure methodological consistency in sequencing, assembly, and metadata reporting across isolates. NMIMR is a major reference laboratory for bacterial genomics in Ghana and has contributed a substantial number of publicly available S. aureus genomes from the country. The selected projects were: PRJNA950924 (registered 31 March 2023): 160 genomes. PRJNA950924 (registered 31 March 2023): 160 genomes. PRJNA588370 (registered 8 November 2019): 25 genomes. PRJNA588370 (registered 8 November 2019): 25 genomes. PRJNA564764 (registered 10 September 2019): 13 genomes. PRJNA564764 (registered 10 September 2019): 13 genomes. PRJNA295807 (registered 8 January 2018): 66 genomes. PRJNA295807 (registered 8 January 2018): 66 genomes. PRJNA283747 (registered 23 September 2015): 21 genomes. PRJNA283747 (registered 23 September 2015): 21 genomes. The combined dataset comprised 285 genome assemblies, which we downloaded from NCBI in FASTA format. Initial quality assessment was performed using Biopython v1.86 via StaphScope v1.1.0 [10] to verify genome completeness and sequence integrity. This included checks for: Minimum sequence length (> 2.5 Mb, typical for S. aureus). Minimum sequence length (> 2.5 Mb, typical for S. aureus). Presence of ambiguous bases (N content < 1%). Presence of ambiguous bases (N content < 1%). Valid nucleotide composition. Valid nucleotide composition. Absence of sequence anomalies. Absence of sequence anomalies. All 285 assemblies passed quality thresholds and were retained for downstream analysis. In silico typing and characterization All 285 genomes were analyzed using the StaphScope pipeline v1.1.0 [10], an integrated workflow for comprehensive S. aureus genomics. StaphScope incorporates multiple established tools: MLST for sequence type assignment [11], spaTyper for spa typing [12], SCCmecFinder for SCCmec typing [13], Abricate for plasmid replicon detection [14], and AMRFinderPlus for antimicrobial resistance gene identification [15]. Virulence factors were detected using the Virulence Factor Database (VFDB) [16] integrated within the pipeline. The pipeline automatically classified isolates as MRSA based on concurrent detection of the mecA gene and an SCCmec element, or as MSSA in the absence of these markers. To facilitate comparative analysis, we intentionally tagged each genome assembly file with its phenotype (MRSA or MSSA) based on this classification. Focus on ST152 lineage Using MLST as implemented in the StaphScope pipeline, we identified ST152 as the dominant sequence type in our dataset (80/285 isolates, 28.1%). We selected these 80 ST152 genomes for detailed comparative genomics to investigate the emergence of methicillin resistance within this successful lineage. Genome annotation and pangenome analysis Genome assemblies were annotated using Prokka v1.14.6 [17] with default parameters. The resulting General Feature Format (GFF) files for all 80 ST152 isolates were used as input for pangenome analysis with Roary v3.13.0 [18] using default parameters (minimum percentage identity for BLASTP = 95%). The gene presence/absence matrix generated by Roary (gene_presence_absence.csv) enabled investigation of gene dissemination patterns between MSSA and MRSA isolates. Phylogenetic analysis For phylogenetic reconstruction, we utilized the core gene alignment generated by Roary (core_gene_alignment.aln), which concatenates 1,937 core genes (shared by ≥ 99% of isolates) into a single multiple sequence alignment of 1,756,218 base pairs. The core gene alignment was inspected for excessive gaps; overall gap proportion was 0.24%, and fewer than 0.1% of columns contained > 50% gaps, indicating good alignment quality. We selected this core gene alignment over a SNP-based phylogeny for several reasons: (1) it maximizes phylogenetic signal by including both synonymous and non-synonymous sites, (2) it provides greater resolution for recently diverged clonal populations, and (3) it represents a well-established approach for studying bacterial population structure [19]. Maximum-likelihood phylogeny was inferred using IQ-TREE v3.0.1 [20] with the following command: iqtree -s core_gene_alignment.aln -m MFP -b 100 -T 2 -pre ST152_core_genes. The ModelFinder Plus (MFP) option selected the best-fit substitution model automatically, and 100 ultrafast bootstrap replicates were performed to assess branch support. Ultrafast bootstrap with 100 replicates has been shown to provide support values comparable to 1000 standard bootstrap replicates [37]; higher replicate numbers would not compensate for the limited phylogenetic signal inherent in this recently diverged population. To account for the potential confounding effects of homologous recombination on phylogenetic inference, we ran ClonalFrameML v1.13 [35] on the initial maximum-likelihood tree and core gene alignment. The analysis was performed with default parameters, and a recombination-corrected phylogeny was generated (ST152_CFML_output.labelled_tree.newick). Default parameters were used because they have been validated for clonal bacterial populations and are appropriate for our dataset size; sensitivity analyses with alternative parameter settings (varying the starting values of R/θ and ν) produced nearly identical tree topologies and recombination estimates. The recombination-masked alignment was also produced for downstream analyses. ClonalFrameML detected 79 recombination events and masked 0.63% of the core genome alignment (10,980 of 1,756,218 bp) (see Supplementary File 1). The corrected tree exhibited a topology nearly identical to the original, confirming that recombination had not distorted the true evolutionary relationships. All phylogenetic trees were visualized and annotated using iTOL (Interactive Tree of Life) [21]. Statistical analysis Differences in prevalence of resistance genes, virulence genes, and plasmid replicons between MSSA and MRSA isolates were assessed using Fisher’s exact test (two-sided). To account for multiple comparisons, we applied the Benjamini-Hochberg false discovery rate (FDR) correction separately to each gene category (resistance, virulence, plasmid). Adjusted p-values (q-values) < 0.05 were considered statistically significant. Unadjusted p-values are reported for transparency and interpreted as exploratory where appropriate. All analyses were performed using Python 3.13 (SciPy package) and R 4.3.3. Results Population structure and genomic characteristics of S. aureus ST152 in Ghana WGS of 285 S. aureus isolates from Ghana identified ST152 as the dominant sequence type, comprising 80 isolates (28.1%). Other frequent sequence types included ST5 (24 isolates, 8.4%), ST250 (21 isolates, 7.4%), ST3249 (20 isolates, 7.0%), and ST15 (17 isolates, 6.0%) (see supplementary file 2 for complete distribution). All 80 ST152 genomes were subjected to detailed characterization (see supplementary file 3). In silico spa typing (which targets the polymorphic X region of the protein A gene, a standard marker for strain relatedness) revealed 13 distinct spa types within the ST152 population, with t355 being predominant (64/80, 80%). The remaining 16 isolates were distributed among 12 other spa types, each represented by one or two isolates (Table 1). This indicates that the ST152 population was dominated by a single successful lineage, despite the presence of a limited number of less frequent spa types. Host information retrieved from BioSample records showed that all 80 ST152 isolates were derived from humans (Homo sapiens); isolation sources included wound exudates, blood, urine, ear swabs, abscesses, and nasal swabs. Table 1Distribution of spa types and methicillin resistance among S. aureus ST152 isolates from GhanaSpa TypeTotal Isolates (n = 80)MSSA (n = 36)MRSA (n = 44)Predominant SCCmec Type in MRSAt35564 (80.0%)2242IV(2B)t10962 (2.5%)11IV(2B)t12992 (2.5%)02IV(2B)t4542 (2.5%)02IV(2B)Other*10 (12.5%)46IV(2B), V, XIII*Other spa types (t11375, t4690, t5468, t4687, t4019, t5047, 07-56-12-17-16-xx-21-12, 07-56-56-12-16-16-33-33-31-57-12, 12-17-16-16-33-31-57-12) occurred as singletons or doubletons. Distribution of spa types and methicillin resistance among S. aureus ST152 isolates from Ghana *Other spa types (t11375, t4690, t5468, t4687, t4019, t5047, 07-56-12-17-16-xx-21-12, 07-56-56-12-16-16-33-33-31-57-12, 12-17-16-16-33-31-57-12) occurred as singletons or doubletons. Notably, MRSA and MSSA isolates were found to co-circulate within the dominant t355 lineage, with 22 MSSA and 42 MRSA isolates sharing this spa type. Among the 44 total MRSA isolates, SCCmec (staphylococcal cassette chromosome mec, the mobile genetic element that carries the methicillin resistance gene mecA) typing revealed a dominance of type IV(2B), present in 42 isolates (95.5%). Single isolates carried SCCmec type V(5C2&5) and the rare type XIII(9 A). The resistome of the ST152 population reveals a core of intrinsic resistance and an MRSA-associated accessory arsenal Analysis of the resistome revealed a conserved core of resistance genes present in all 80 ST152 isolates, alongside a suite of accessory genes whose distribution delineates the methicillin-resistant subset (Table 2). A core of chromosomally-encoded determinants conferring baseline resistance to tetracyclines (tet(38)), fluoroquinolones (norA, norB, norC), disinfectants (mepA), and fosfomycin (glpT_A100V, murA_E291D/T396N) was universal. Table 2Comprehensive resistome of S. aureus ST152 in Ghana, stratified by methicillin resistance phenotype, with false discovery rate (FDR) correctionGeneResistance ClassMSSA (n = 36)MRSA (n = 44)Raw p-valueq-value¹Significant²Core (universal) tet(38) Tetracycline efflux36 (100%)44 (100%)––– mepA Multidrug efflux36 (100%)44 (100%)––– norA/B/C Fluoroquinolone efflux36 (100%)44 (100%)––– glpT_A100VFosfomycin transport36 (100%)44 (100%)––– murA_E291D/T396NFosfomycin target36 (100%)44 (100%)–––Methicillin resistance mecA PBP2a0 (0%)44 (100%)< 0.001–– mecR1 SCCmec regulator0 (0%)43 (97.7%)< 0.001––Accessory resistance blaZ Beta-lactamase (penicillin)28 (77.8%)44 (100%)0.0010.005Yes catA Chloramphenicol acetyltransferase14 (38.9%)36 (81.8%)< 0.0010.002Yes tet(K) Tetracycline efflux11 (30.6%)19 (43.2%)0.3530.589No erm(C) Macrolide resistance0 (0%)2 (4.5%)0.4990.712No dfrG Trimethoprim resistance0 (0%)1 (2.3%)1.0001.000No aac(6’)-Ie/aph(2’’)-Ia Aminoglycoside resistance0 (0%)1 (2.3%)1.0001.000No qnrD3 Quinolone resistance0 (0%)1 (2.3%)1.0001.000No str Streptomycin resistance3 (8.3%)0 (0%)0.0870.174No blaZ_78 Beta-lactamase variant3 (8.3%)0 (0%)0.0870.174No rpoB mutationsRifampin resistance3 (8.3%)0 (0%)0.0870.174No¹ q-values calculated using Benjamini-Hochberg FDR correction for the 10 accessory resistance genes² “Significant” means q < 0.05. Dashes (–) indicate genes not subjected to statistical testing (present in 100% of both groups or defining MRSA status) Comprehensive resistome of S. aureus ST152 in Ghana, stratified by methicillin resistance phenotype, with false discovery rate (FDR) correction ¹ q-values calculated using Benjamini-Hochberg FDR correction for the 10 accessory resistance genes ² “Significant” means q < 0.05. Dashes (–) indicate genes not subjected to statistical testing (present in 100% of both groups or defining MRSA status) The definitive genetic boundary within the lineage was the mecA gene, which – together with its regulator mecR1 – was exclusive to and ubiquitous within the MRSA subset (100% and 97.7% prevalence, respectively), confirming perfect phenotype-genotype concordance. Penicillin resistance mediated by the blaZ β-lactamase gene was present in 90.0% (72/80) of isolates but was significantly enriched in MRSA (100% of MRSA vs. 77.8% of MSSA; raw p = 0.001, q = 0.005 after FDR correction). Similarly, chloramphenicol resistance (catA) was significantly more prevalent in MRSA (81.8%) than in MSSA (38.9%) (raw p < 0.001, q = 0.002). In contrast, the tetracycline efflux gene tet(K) showed a higher prevalence in MRSA (43.2%) than in MSSA (30.6%), but this difference was not statistically significant after correction (raw p = 0.353, q = 0.589). A collection of clinically significant resistance determinants for aminoglycosides (aac(6’)-Ie/aph(2’’)-Ia), macrolides (erm(C)), trimethoprim (dfrG), and quinolones (qnrD3) were found exclusively in MRSA isolates, albeit at low individual prevalence. None of these reached statistical significance after FDR correction due to their rarity. Conversely, streptomycin resistance (str), a specific blaZ variant (blaZ_78), and rifampin resistance-conferring rpoB mutations were unique to a small number of MSSA isolates (raw p = 0.087, q = 0.174 for each). This analysis demonstrates that while the ST152 lineage carries a stable core resistome, the MRSA subset acts as the primary reservoir for the accumulation of diverse, high-priority accessory resistance genes. The strong linkage between the SCCmec element and other resistance genes suggests this successful lineage is evolving under substantial antimicrobial pressure. The ST152 lineage carries a conserved, extensive virulence arsenal with higher prevalence of key adhesins and toxins in MRSA isolates Virulence factor profiling revealed a well-equipped lineage. All 80 isolates possessed a complete capsule type 8 biosynthesis cluster (cap8A-P), the complete biofilm operon (icaADBCR), and the ESS type VII secretion system (esa/esx/ess genes). The immune evasion cluster gene scn was universal, and the sbi gene (IgG-binding) was present in all isolates. All isolates carried the lukF-PV gene, and the majority also carried lukS-PV (97.7% of MRSA, 86.1% of MSSA). Functional PVL requires both subunits; thus, the toxin is likely produced in most MRSA and a large proportion of MSSA. The core toxin profile also included gamma-hemolysin (hlgABC) and alpha-hemolysin (hla) in > 98% of isolates. Comparison of virulence gene prevalence between MSSA and MRSA isolates after false discovery rate (FDR) correction revealed that the collagen adhesin cna and the exfoliative toxin gene ete were significantly enriched in MRSA (Table 3). The cna gene was present in 75.0% (33/44) of MRSA isolates compared to 36.1% (13/36) of MSSA isolates (raw p = 0.001, q = 0.006). The ete gene was found in 95.5% (42/44) of MRSA vs. 75.0% (27/36) of MSSA (raw p = 0.010, q = 0.047). Table 3Differential prevalence of key virulence genes in MSSA and MRSA isolates with FDR correctionVirulence GeneFunctionMSSA (n = 36)MRSA (n = 44)Raw p-valueq-value¹Significant² lukS-PV PVL subunit (with lukF-PV)31 (86.1%)43 (97.7%)0.0850.192No cna Collagen adhesin13 (36.1%)33 (75.0%)0.0010.006Yes spa Protein A (immune evasion)30 (83.3%)43 (97.7%)0.0420.125No ete Exfoliative toxin E27 (75.0%)42 (95.5%)0.0100.047Yes clfA Clumping factor A33 (91.7%)43 (97.7%)0.3220.483No clfB Clumping factor B33 (91.7%)43 (97.7%)0.3220.483No esaE ESS secretion system35 (97.2%)44 (100%)0.4500.499No hlb Beta-hemolysin35 (97.2%)44 (100%)0.4500.499No sea Enterotoxin A0 (0%)2 (4.5%)0.4990.499No¹ q-values calculated using Benjamini-Hochberg FDR correction for the 9 virulence genes² Significant if q < 0.05 Differential prevalence of key virulence genes in MSSA and MRSA isolates with FDR correction ¹ q-values calculated using Benjamini-Hochberg FDR correction for the 9 virulence genes ² Significant if q < 0.05 Other virulence factors showed trends but did not reach statistical significance after correction. The spa gene (protein A) was present in 97.7% of MRSA and 83.3% of MSSA (raw p = 0.042, q = 0.125). The PVL subunit lukS-PV was carried by 97.7% of MRSA and 86.1% of MSSA (raw p = 0.085, q = 0.192). No significant differences were observed for clfA, clfB, esaE, hlb, or sea. Plasmid replicon distribution reveals enrichment of a specific plasmid family in MRSA isolates Plasmid content analysis identified 16 distinct plasmid replicon types across the 80 isolates (Table 4). After false discovery rate (FDR) correction, only the replicon rep7a_5_repD(pTZ4) was significantly enriched in MRSA isolates. It was present in 75.0% (33/44) of MRSA isolates compared to 27.8% (10/36) of MSSA isolates (raw p = 0.000038, q = 0.0006). This replicon family is known to carry resistance genes in staphylococci and may contribute to the higher prevalence of accessory resistance genes observed in MRSA isolates. Table 4Distribution of major plasmid replicons among MSSA and MRSA isolates with FDR correctionPlasmid RepliconTotal (n = 80)MSSA (n = 36)MRSA (n = 44)Raw p-valueq-value¹Significant²High prevalence (> 50%) rep16_3_rep(pSaa6159) 73 (91.3%)30 (83.3%)43 (97.7%)0.04170.222No rep5a_1_repSAP001(pN315) 72 (90.0%)29 (80.6%)43 (97.7%)0.01980.159NoModerate prevalence (25–50%) rep7a_5_repD(pTZ4) 43 (53.8%)10 (27.8%)33 (75.0%)0.0000380.0006YesLow prevalence (6–25%) rep7a_16_repC(Cassette) 20 (25.0%)6 (16.7%)14 (31.8%)0.1940.456No rep7a_10_ORF(pKH1) 6 (7.5%)4 (11.1%)2 (4.5%)0.4010.655NoMSSA-exclusive rep7a_4_repD(pK214) 3 (3.8%)3 (8.3%)0 (0%)0.0870.348No rep19_9_repA(AP071A) 2 (2.5%)2 (5.6%)0 (0%)0.1990.456No rep16_2_CDS6(pSJH101) 2 (2.5%)2 (5.6%)0 (0%)0.1990.456No rep24a_1_rep(pWBG745) 1 (1.2%)1 (2.8%)0 (0%)0.4500.655No rep21_22_CDS1(pUSA01) 1 (1.2%)1 (2.8%)0 (0%)0.4500.655No Col(MG828)_1 1 (1.2%)1 (2.8%)0 (0%)0.4500.655NoMRSA-exclusive rep10_3_pNE131p1(pNE131) 2 (2.5%)0 (0%)2 (4.5%)0.4990.665No rep5e_2_SAP018B003(SAP018B) 1 (1.2%)0 (0%)1 (2.3%)1.0001.000No rep7a_7_rep(pKH7) 1 (1.2%)0 (0%)1 (2.3%)1.0001.000No rep5c_1_rep(pRJ9) 1 (1.2%)0 (0%)1 (2.3%)1.0001.000No Col3M_1 1 (1.2%)0 (0%)1 (2.3%)1.0001.000No¹ q-values calculated using Benjamini-Hochberg FDR correction for the 16 plasmid replicons² Significant if q < 0.05 Distribution of major plasmid replicons among MSSA and MRSA isolates with FDR correction ¹ q-values calculated using Benjamini-Hochberg FDR correction for the 16 plasmid replicons ² Significant if q < 0.05 Two high-prevalence replicons, rep16_3_rep(pSaa6159) and rep5a_1_repSAP001(pN315), showed trends towards enrichment in MRSA (97.7% vs. 83.3% and 97.7% vs. 80.6%, respectively), but neither reached statistical significance after FDR correction (raw p = 0.0417, q = 0.222; and raw p = 0.0198, q = 0.159, respectively). Several rare replicons showed exclusive association with one phenotype: six replicons were found only in MSSA isolates (rep7a_4_repD(pK214), rep19_9_repA(AP071A), rep16_2_CDS6(pSJH101), rep24a_1_rep(pWBG745), rep21_22_CDS1(pUSA01), and Col(MG828)_1), while five were exclusive to MRSA isolates (rep10_3_pNE131p1(pNE131), rep5e_2_SAP018B003(SAP018B), rep7a_7_rep(pKH7), rep5c_1_rep(pRJ9), and Col3M_1). However, due to their low frequency and the multiple testing correction, none of these exclusive distributions were statistically significant (all q ≥ 0.348). This suggests differential plasmid carriage between the two populations, potentially driven by selective pressures associated with the healthcare environment or antibiotic exposure, but larger sample sizes would be needed to confirm these patterns. Pangenome analysis reveals SCCmec-associated genes and differential accessory genome content Pangenome analysis of the 80 ST152 isolates identified a core genome of 1,937 genes (shared by ≥ 99% of isolates) and an accessory genome of 1,562 genes (Fig. 1). Comparative analysis revealed 78 genes significantly enriched in MRSA isolates (prevalence difference > 20%, present in ≥ 10% of MRSA) and 21 genes enriched in MSSA isolates (Table 5). All MRSA-specific genes were associated with the SCCmec element, including the methicillin resistance determinant mecA (0% MSSA vs. 100% MRSA), its regulator mecR1 (0% vs. 97.7%), and five hypothetical proteins (groups 1329–1333; 0% vs. 95.5%). Two additional genes, ugpQ (glycerophosphodiester phosphodiesterase) and gloB (hydroxyacylglutathione hydrolase), were present exclusively in MRSA isolates and may represent flanking chromosomal regions or additional SCCmec-associated functions. Conversely, MSSA isolates harbored several unique genes, most notably a Type VII secretion system component (esaG; 91.7% MSSA vs. 4.5% MRSA) and a linearmycin resistance gene (58.3% vs. 9.1%). The near-complete absence of these genes in MRSA suggests potential gene loss following SCCmec acquisition or differential selection pressures. Pangenome composition of 80 ST152 S. aureus isolates Table 5Select differentially prevalent genes between MSSA and MRSA isolatesGeneAnnotationMSSA (n = 36)MRSA (n = 44)DifferenceMRSA-enriched mecA_1 PBP2a (methicillin resistance)0%100%+ 100% mecR1 SCCmec regulator0%97.7%+ 97.7% ugpQ Glycerophosphodiesterase0%100%+ 100% gloB Hydroxyacylglutathione hydrolase0%97.7%+ 97.7%MSSA-enriched group_924 Type VII secretion system EsaG91.7%4.5%-87.2% group_286 Hypothetical protein97.2%6.8%-90.4% group_609 Linearmycin resistance58.3%9.1%-49.2% Select differentially prevalent genes between MSSA and MRSA isolates Other antibiotic resistance genes showed variable patterns: the bifunctional aminoglycoside resistance gene aacA-aphD was detected in only one MRSA isolate (2.3%), while tetracycline resistance genes were uniformly present. Virulence genes, including leukocidin variants (lukEv, lukDv), were conserved across both populations (> 97% prevalence). All differences were statistically significant by Fisher’s exact test (p < 0.001 for each gene). No multiple testing correction was applied because the genes were pre-selected based on large prevalence differences (> 20%) and presence in ≥ 10% of MRSA isolates. The pie chart shows the distribution of gene categories based on Roary analysis: Core genes – present in ≥ 99% of isolates (n = 1,937). Core genes – present in ≥ 99% of isolates (n = 1,937). Soft core genes – present in 95–99% of isolates (n = 410; nearly universal but absent in a few strains). Soft core genes – present in 95–99% of isolates (n = 410; nearly universal but absent in a few strains). Shell genes – present in 15–95% of isolates (n = 339; moderately common, often subgroup-specific). Shell genes – present in 15–95% of isolates (n = 339; moderately common, often subgroup-specific). Cloud genes – present in < 15% of isolates (n = 813; rare or strain-specific). Cloud genes – present in < 15% of isolates (n = 813; rare or strain-specific). The total pangenome comprises 3,499 gene clusters. The total pangenome comprises 3,499 gene clusters. Core-genome phylogeny suggests multiple independent SCCmec acquisitions To reconstruct the evolutionary history of the Ghanaian ST152 lineage and explore whether methicillin resistance arose from a single or multiple SCCmec acquisition events, we performed maximum-likelihood phylogenetic inference based on the concatenated alignment of 1,937 core genes (1,756,218 bp). The resulting tree exhibited extremely short branch lengths (mean = 1.29 × 10⁻⁵ substitutions per site), reflecting the highly clonal and recently diverged nature of this population (Supplementary Figure S1). Bootstrap support for most internal nodes was low to moderate (median = 41, range 0–100), consistent with the limited number of parsimony-informative sites (526) and a star-like topology characteristic of rapid clonal expansion. Consequently, the branching order within the tree should be interpreted with caution. ClonalFrameML detected significant recombination (log-likelihood ratio = 8365, R/θ = 0.055, mean import length ≈ 145 bp), confirming that recombination has occurred within the ST152 population. However, the recombination-corrected tree (Fig. 2) exhibited a topology nearly identical to the original uncorrected tree (Supplementary Figure S1), with MRSA isolates remaining interspersed among MSSA. This suggests that recombination has not substantially distorted the observed phylogenetic patterns, which are consistent with multiple independent acquisitions of SCCmec. Recombination-corrected core-genome phylogeny of S. aureus ST152 from Ghana Methicillin-resistant and -susceptible isolates are intermixed throughout the phylogeny The innermost annotation ring (MRSA_status) showed that MRSA (red) and MSSA (green) isolates are broadly interspersed across the tree rather than forming a single monophyletic MRSA lineage (Fig. 2). MRSA appeared in at least four distinct phylogenetic clusters, separated by MSSA branches and, in some cases, by MRSA carrying alternative SCCmec types. Notably, the two MRSA isolates harbouring the rare SCCmec variants – type V(5C2&5) and type XIII(9 A) – each occupied a solitary position deep within otherwise MSSA-dominated clades, which is consistent with independent acquisition events that did not lead to subsequent clonal expansion. Two additional type IV MRSA isolates were also found intermingled with MSSA in separate parts of the tree, further supporting recurrent SCCmec entry into the ST152 population. Conversely, within the largest MRSA-enriched cluster, three MSSA isolates were embedded among numerous MRSA. These MSSA may represent either recent loss of the SCCmec element or ancestral lineages that never acquired resistance, underscoring the dynamic nature of methicillin resistance in this lineage. SCCmec type IV is widespread but not confined to a single clade The second ring displays SCCmec genotypes (Fig. 2). SCCmec type IV(2B) was carried by 42 of the 44 MRSA isolates (95.5%) and was distributed across multiple, non-adjacent branches. While a major MRSA clade contained the majority of type IV isolates, the remaining type IV strains were scattered across two to three additional lineages, each separated by MSSA or rare SCCmec types. This distribution argues against a single, clonal origin of methicillin resistance and is instead consistent with multiple independent acquisitions of the type IV cassette, with at least one successful expansion event giving rise to the predominant MRSA subpopulation. spa type diversity is lineage-specific and dominated by t355 The third ring illustrates spa types (Fig. 2). As expected, the dominant t355 allele (80% of isolates) was present throughout the phylogeny, consistent with its role as the ancestral background. All other spa types (e.g., t1096, t1299, t454) were strictly confined to single isolates or small, well-defined clades, and were almost exclusively associated with MSSA or the rare SCCmec variant carriers. This pattern suggests that spa diversification occurs through point mutations or small recombination events within individual lineages, rather than through large-scale horizontal transfer. Accessory resistance, virulence, and plasmid markers are enriched in specific MRSA subclades The fifth, sixth, and seventh rings (Fig. 2) respectively represent the presence of key acquired resistance genes (e.g., catA, tet(K)), virulence (the collagen adhesin gene cna), and the plasmid replicon rep7a_5_repD(pTZ4). All three markers exhibited strong phylogenetic clustering: they were almost exclusively present in the two largest MRSA-containing clades, and were nearly absent from MSSA and from the singleton MRSA carrying rare SCCmec types. This lineage-specific enrichment suggests that these accessory elements were acquired after the emergence of those particular MRSA sublineages and have been stably maintained. The tight co-occurrence of rep7a_5_repD, catA, and cna within the same clades raises the possibility that these traits are physically linked, either on a common mobile genetic element or through co-selection. Summary of phylogenetic evidence Taken together, the core-genome phylogeny, both before and after recombination correction, is consistent with a model in which the Ghanaian ST152 population has experienced multiple independent acquisitions of SCCmec elements, with SCCmec type IV(2B) entering the lineage on at least three separate occasions. One of these events gave rise to a large, successful MRSA subclade that subsequently accumulated additional resistance determinants, a collagen adhesin, and a specific plasmid replicon – features that may confer enhanced fitness under antimicrobial and host-colonization selection pressures. The rare SCCmec types V and XIII represent independent, non-expanded acquisitions. The presence of MSSA within the major MRSA clade hints at ongoing SCCmec loss or retention of susceptible ancestors. However, the low bootstrap support for many internal nodes limits the certainty of the exact branching order, and the observed patterns should be interpreted as suggestive rather than definitive. Nonetheless, the polyphyletic distribution of MRSA, which remained robust after recombination correction, contrasts with a simple model of single-lineage expansion and highlights the evolutionary flexibility of ST152 as a vehicle for methicillin resistance in Ghana. Tree inferred from 1,937 core genes (1,756,218 bp) after masking recombinant regions with ClonalFrameML. From inner to outer rings: (1) phenotype (red = MRSA, green = MSSA); (2) SCCmec type; (3) spa type; (4) MLST (all ST152); (5) accessory resistance genes; (6) virulence gene; (7) plasmid replicon. MRSA isolates are distributed across multiple clades (appear polyphyletic), with SCCmec type IV found in several non-adjacent branches. Rare SCCmec types V and XIII occupy singleton positions among MSSA. Accessory traits are enriched in specific MRSA subclades, consistent with lineage-specific evolution after independent SCCmec acquisitions. Branch lengths are corrected for recombination. Scale bar: 0.0001 substitutions per site. Discussion S. aureus ST152 is a globally disseminated lineage associated with community-acquired infections and has been reported in several West African countries [31–34]. In this study, we analyzed 80 ST152 genomes from Ghana to investigate the evolutionary origins of methicillin resistance within this lineage. Our findings are consistent with a model in which MRSA has emerged repeatedly through multiple independent SCCmec acquisitions, with one lineage subsequently acquiring additional resistance and virulence traits to become the dominant MRSA subpopulation in Ghana. The core-genome phylogeny showed that MRSA and MSSA isolates are extensively intermixed, with MRSA appearing in at least four distinct phylogenetic clusters. After correcting for recombination with ClonalFrameML, the interspersed pattern remained, suggesting that the observed distribution is not simply an artifact of recombination. The two isolates carrying rare SCCmec variants (type V and type XIII) each occupied a solitary position within otherwise MSSA-dominated branches, which is consistent with independent acquisition events that did not lead to clonal expansion. Two additional type IV MRSA isolates were also found intermingled with MSSA in separate parts of the tree, further supporting recurrent SCCmec entry into the ST152 population. Similar patterns of multiple independent acquisitions have been observed in other successful S. aureus lineages and appear to be a common feature of MRSA evolution in high-exposure settings [22, 23]. However, the low bootstrap support for many internal nodes (median 41) limits the certainty of the exact branching order, and alternative topologies (including a single origin with subsequent spread) cannot be completely ruled out. Despite evidence of multiple independent acquisitions, most MRSA isolates belonged to a single expanded lineage. Within the largest MRSA-enriched cluster, a distinct subpopulation carried the majority of SCCmec type IV isolates and was characterized by the presence of several accessory traits largely absent from other MRSA and from most MSSA: the chloramphenicol resistance gene catA, the tetracycline efflux gene tet(K) (though not significant after multiple testing correction), the collagen adhesin cna, and the plasmid replicon rep7a_5_repD(pTZ4). The collagen adhesin cna promotes adherence to host extracellular matrix and has been associated with increased virulence in experimental models [24, 25]; its enrichment in this subpopulation may enhance colonization and transmission. The plasmid replicon rep7a_5_repD(pTZ4), which was significantly enriched in MRSA after FDR correction, has been previously associated with carriage of resistance genes in staphylococci [26, 27]. Its co-occurrence with catA and cna raises the possibility that these traits are physically linked on a common mobile genetic element. The lack of statistical significance for many other accessory resistance and virulence genes after FDR correction (e.g., tet(K), lukS-PV, spa, and several plasmid replicons) likely reflects their low prevalence in the dataset and limited statistical power, rather than a true absence of biological association. Larger sample sizes would be required to detect such rare events. Three MSSA isolates were found embedded within the largest MRSA-enriched cluster. These MSSA were phylogenetically indistinguishable from their MRSA counterparts but lacked the SCCmec element. They may represent ancestral lineages that never acquired SCCmec or may have undergone secondary loss of the element, a phenomenon documented in other S. aureus lineages under reduced antibiotic selective pressure [28, 29]. Regardless, their presence underscores the dynamic nature of methicillin resistance. The universal presence of the immune evasion gene scn – a marker typical of human-adapted S. aureus – in all ST152 isolates is consistent with the exclusively human origin confirmed by BioSample metadata [36]. Combined with the enrichment of the collagen adhesin in the dominant lineage, ST152 appears well equipped for both colonization and disease causation. This combination of resistance and virulence traits may contribute to the epidemiological success of ST152 in Ghana and other West African countries, consistent with recent genomic surveillance documenting the expansion of this lineage across Ghanaian hospitals [1, 30]. The co-circulation of MRSA and MSSA within the same phylogenetic clusters also implies that SCCmec acquisition could occur at any time, underscoring the need for continued surveillance. Limitations This study has several limitations. First, phylogenetic inference was constrained by low bootstrap support at many internal nodes (median 41), reflecting limited phylogenetic signal due to recent clonal expansion. Therefore, while the observed interspersion of MRSA and MSSA is consistent with multiple independent SCCmec acquisitions, alternative evolutionary scenarios cannot be definitively excluded. Second, we opted to use a core-genome alignment from assemblies rather than reference-based SNP calling from raw reads to avoid biases associated with using a non-African, non-ST152 reference genome. While this approach is appropriate for analysing recently diverged clonal populations and maximizes phylogenetic signal, it may offer lower resolution than a raw-read SNP analysis for detecting fine-scale microevolutionary events. Third, the use of assembled genomes limited our ability to fully resolve plasmid structures and definitively establish physical linkage between mobile elements and accessory resistance genes. Fourth, the dataset was restricted to publicly available genomes, which may not capture the full diversity of ST152 circulating in Ghana. Fifth, the absence of clinical metadata precluded associations between genomic features and disease outcomes or antibiotic exposure. Sixth, the rare SCCmec type XIII(9 A) detected in a single isolate was identified by k-mer-based typing with high template coverage (99.6%), but due to fragmented assembly the complete cassette structure could not be confirmed by gene-based methods; therefore this assignment should be considered provisional and would benefit from validation using alternative typing approaches. Seventh, statistical power was limited for low-prevalence genetic features, and functional validation was beyond the scope of this bioinformatic analysis. Consequently, claims of enhanced virulence or specialized adaptation are speculative and should be interpreted with caution. Conclusion This study provides evidence consistent with the emergence of methicillin resistance in S. aureus ST152 from Ghana through multiple independent acquisitions of SCCmec elements. Despite these varied origins, a single MRSA sublineage has become dominant, distinguished by the acquisition of additional resistance genes (e.g., catA), the collagen adhesin (cna), and a specific plasmid replicon (rep7a_5_repD(pTZ4)). The presence of MSSA isolates phylogenetically embedded within MRSA clusters suggests an ongoing dynamic of SCCmec gain and loss within this population. The universal carriage of PVL and the enrichment of colonization factors in the dominant lineage indicate that ST152 is well equipped for both transmission and disease causation. These findings highlight the evolutionary flexibility of ST152 as a vehicle for methicillin resistance in West Africa and underscore the critical need for sustained genomic surveillance to monitor the emergence and spread of high-risk lineages in the region. Supplementary Information Additional file 1: Supplementary Figure S1: Original uncorrected core-genome phylogeny of S. aureus ST152 from Ghana. Additional file 2: Recombination masked core genome alignment (FASTA) along with other supporting data. Additional file 3: List of all 285 S. aureus isolates analyzed in this study and their genomic characteristics including STs, spa types, SCCmec, and their resistance profiles. Additional file 4: Genomic characteristics of the 80 ST152 isolates. Acknowledgements The authors thank the researchers and sequencing teams at the Noguchi Memorial Institute for Medical Research, University of Ghana, particularly those involved in generating the genome sequences under BioProjects PRJNA950924, PRJNA588370, PRJNA564764, PRJNA295807, and PRJNA283747. We also acknowledge the National Center for Biotechnology Information (NCBI) and the European Nucleotide Archive (ENA) for maintaining public repositories that enable data sharing and reuse. Finally, we are grateful to the editors and anonymous reviewers for their thoughtful comments, constructive suggestions, and the time and effort they dedicated to improving this manuscript. AI use statement The authors used Deepseek AI to assist with language refinement and manuscript preparation. The scientific content, analyses, and interpretations are solely the authors’ own work. Authors’ contributions B.B. and V.A. conceived the study. B.B. performed computational analyses and drafted the manuscript. V.A., A.O., and I.A contributed to data interpretation and manuscript revision. All authors read and approved the final manuscript. Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Data availability All genome assemblies analysed in this study are publicly available in the NCBI database under BioProjects PRJNA950924, PRJNA588370, PRJNA564764, PRJNA295807, and PRJNA283747. Declarations Ethics approval and consent to participate Not applicable. This study used only publicly available genome sequences and did not involve direct human or animal subjects, clinical samples, or identifiable patient data. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Brown Beckley and Vincent Amarh contributed equally to this work. References Associated Data Data Citations Supplementary Materials Additional file 1: Supplementary Figure S1: Original uncorrected core-genome phylogeny of S. aureus ST152 from Ghana. Additional file 2: Recombination masked core genome alignment (FASTA) along with other supporting data. Additional file 3: List of all 285 S. aureus isolates analyzed in this study and their genomic characteristics including STs, spa types, SCCmec, and their resistance profiles. Additional file 4: Genomic characteristics of the 80 ST152 isolates. Data Availability Statement All genome assemblies analysed in this study are publicly available in the NCBI database under BioProjects PRJNA950924, PRJNA588370, PRJNA564764, PRJNA295807, and PRJNA283747.